Home » Clinical Trials » Leukemia » NCT06906380
NCT06906380

A Long-term Follow-up Study of Patients Enrolled in ARD103_ARCE-CL-P-001 Phase 1/2 Study and Treated With ARD103 CAR-T Cell Therapies

Study Summary

This study will evaluate the long-term safety of ARD103 cellular therapies

Want to learn more about this trial?

Request More Info

Interventions

Non interventional studyOTHER
Non Intervention, an observation LTFU study

Study Locations

FacilityCityStateCountry
Novant Health Cancer InstituteCharlotteNorth CarolinaUnited States
Novant Health Cancer InstituteWinston-SalemNorth CarolinaUnited States
MD Anderson Cancer CenterHoustonTexasUnited States

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026